tiprankstipranks
SpringWorks Therapeutics price target raised to $87 from $65 at BofA
PremiumThe FlySpringWorks Therapeutics price target raised to $87 from $65 at BofA
8d ago
SpringWorks Therapeutics CEO sells $2.56M in common stock
Premium
The Fly
SpringWorks Therapeutics CEO sells $2.56M in common stock
9d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9d ago
SpringWorks Therapeutics price target raised to $66 from $63 at TD Cowen
PremiumThe FlySpringWorks Therapeutics price target raised to $66 from $63 at TD Cowen
9d ago
Springworks Therapeutics Gains FDA Approval for GOMEKLI
Premium
Company Announcements
Springworks Therapeutics Gains FDA Approval for GOMEKLI
9d ago
Buy Rating for Springworks Therapeutics Boosted by FDA Approval of GOMEKLI and Strong Market Potential
Premium
Ratings
Buy Rating for Springworks Therapeutics Boosted by FDA Approval of GOMEKLI and Strong Market Potential
9d ago
Merck KGaA confirms ‘advanced’ talks to acquire SpringWorks
PremiumThe FlyMerck KGaA confirms ‘advanced’ talks to acquire SpringWorks
11d ago
SpringWorks shares up 39% to $55.90 after Merck KGaA confirms talks
Premium
The Fly
SpringWorks shares up 39% to $55.90 after Merck KGaA confirms talks
11d ago
SpringWorks Therapeutics trading resumes
Premium
The Fly
SpringWorks Therapeutics trading resumes
11d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100